Document is current
Any future updates will be listed below
-
Authors
Junqueira, Daniela R.
Bennett, Dimitri http://orcid.org/0000-0002-8387-9342
Huh, Susanna Y.
Fahrbach, Kyle
Neupane, Binod
Betts, Marissa
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
- License Information
-
More Information
Article History
Accepted: 22 January 2023
First Online: 7 February 2023
Declarations
:
: This study was sponsored by Takeda Development Center Americas, Inc.
: Dr. Bennett and Dr. Huh are current and former employees, respectively, of Takeda Development Center Americas, Inc., and received stock or stock options at the time of study. Currently, Dr. Huh is with Ironwood Pharmaceuticals. Dr. Junqueira, Ms. Betts, Dr. Fahrbach, and Dr. Neupane provided consultancy support to Takeda Development Center Americas, Inc., as employees of Evidera.
: None required.
: Not applicable.
: Not applicable.
: All data generated or analyzed during this study are included in this published article [and its supplementary information files].
: Not applicable.
: Dr. Junqueira, Dr. Bennett, Dr. Huh, and Ms. Betts led the research conceptualization and methodology. Dr. Junqueira led the data curation, investigation, project administration, and visualization. Dr. Fahrbach and Dr. Neupane led the analysis in collaboration with Dr Junqueira and Ms Betts. Dr. Junqueira wrote the original draft and worked with all co-authors in reviewing and editing the final manuscript. All authors reviewed and approved the final manuscript.
